Fig. 2
From: Impact of selenium status and supplementation on outcomes in critically ill patients
Comparison of clinical and laboratory parameters between patients with serum selenium levels < 70 µg/L and ≥ 70 µg/L. (a) APACHE II score was significantly higher in the selenium-deficient group (24.7 ± 9.3) compared to those with normal selenium levels (20.1 ± 7.8), p = 0.003. (b) SOFA score was higher in selenium-deficient patients (8.6 ± 4.3 vs. 6.6 ± 3.9), p = 0.012. (c) TISS score was elevated in patients with selenium < 70 µg/L (31.4 ± 9.4 vs. 28.1 ± 7.0), p = 0.023. (d) Plasma 25-hydroxyvitamin D concentration was lower in the selenium-deficient group (16.0 ± 7.5 ng/mL vs. 22.6 ± 9.3 ng/mL), p < 0.001. (e) Serum CRP was significantly higher in selenium-deficient patients (162.4 ± 99.2 mg/L) compared to those with selenium ≥ 70 µg/L (82.1 ± 81.0 mg/L), p < 0.001.
